The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2019.00296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Propolis Supplementation Improves Glycemic and Antioxidant Status in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study

Complementary Therapies in Medicine
Alternative MedicineManual TherapySpecialized NursingAdvancedComplementary
2019English

Transglucosidase Improves the Bowel Movements in Type 2 Diabetes Mellitus Patients: A Preliminary Randomized Double-Blind, Placebo-Controlled Study

United European Gastroenterology Journal
OncologyGastroenterology
2017English

Effect of Linagliptin and Voglibose on Metabolic Profile in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

BMC pharmacology & toxicology
MedicinePharmacology
2018English

The Effect of Probiotic Supplementation on Glycemic Control and Lipid Profile in Patients With Type 2 Diabetes: A Randomized Placebo Controlled Trial

Diabetes and Metabolic Syndrome: Clinical Research and Reviews
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2019English

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2018English

Glimepiride Treatment and IGF-I in Adolescents With Type 1 Diabetes: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Effects of Fenofibrate on Albuminuria in Patients With Hypertriglyceridemia and/or Hyperuricemia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Current Therapeutic Research
Pharmacology
2003English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Randomized, Double-Blind, Placebo-Controlled Trial of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Asian Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin With or Without a Sulfonylurea (GetGoal-L-Asia)

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy